Beam Therapeutics Ownership 2024 | Who Owns Beam Therapeutics Now?


OverviewForecastRevenueFinancialsChart

Institutional Ownership

57.16%

Insider Ownership

1.52%

Retail Ownership

41.32%

Institutional Holders

154.00

Beam Therapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARK INVESTMENT MANAGEMENT LLC10.61%1.87%8,182,174-1,211,715-12.90%270,339,043,000Mar 31, 2024
VANGUARD GROUP INC9.82%0.01%7,578,768413,8925.78%250,402,494Mar 31, 2024
BLACKROCK INC.8.69%0.01%6,705,62643,5830.65%221,553,881Mar 31, 2024
FMR LLC6.34%0.01%4,894,453-1,285,869-20.81%161,712,727Mar 31, 2024
FARALLON CAPITAL MANAGEMENT LLC5.85%0.67%4,511,753406,0009.89%149,068,319Mar 31, 2024
MORGAN STANLEY5.34%0.01%4,123,575-60,767-1.45%136,242,931Mar 31, 2024
STATE STREET CORP4.84%0.01%3,731,192-885,166-19.17%123,278,584Mar 31, 2024
SUMITOMO MITSUI TRUST HOLDINGS, INC.3.06%0.05%2,361,8173,7260.16%78,034,434Mar 31, 2024
NIKKO ASSET MANAGEMENT AMERICAS, INC.3.06%0.77%2,361,8173,7260.16%77,892,725Mar 31, 2024
MWG MANAGEMENT LTD.3.04%57.42%2,346,934--77,542,699Mar 31, 2024
DARWIN GLOBAL MANAGEMENT, LTD.2.75%9.32%2,119,5982,119,598100.00%70,031,518Mar 31, 2024
REDMILE GROUP, LLC2.44%2.28%1,879,617449,83431.46%62,102,546Mar 31, 2024
TEMASEK HOLDINGS (PRIVATE) LTD2.35%0.33%1,812,972-1,263,145-41.06%59,900,595Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC2.12%0.01%1,636,72261,4433.90%54,084,827Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/1.62%0.01%1,246,1891,207,6993137.70%41,175,000Mar 31, 2024
BELLEVUE GROUP AG1.55%0.60%1,193,121498,30071.72%39,420,718Mar 31, 2024
YIHENG CAPITAL MANAGEMENT, L.P.1.10%1.55%845,500--27,935,320Mar 31, 2024
BAILLIE GIFFORD & CO0.98%0.02%752,394-11,729-1.53%24,859,099Mar 31, 2024
CASDIN CAPITAL, LLC0.87%1.66%675,000147,00027.84%22,302,000Mar 31, 2024
NORTHERN TRUST CORP0.85%0.00%659,180-9,362-1.40%21,779,307Mar 31, 2024

Beam Therapeutics's largest institutional shareholder is ARK INVESTMENT MANAGEMENT LLC, holding 10.61% of the company's total share outstanding, currently valued at $270.34B. The top 10 institutional shareholders own together 60.66% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MWG MANAGEMENT LTD.3.04%57.42%2,346,934--77,542,699Mar 31, 2024
DARWIN GLOBAL MANAGEMENT, LTD.2.75%9.32%2,119,5982,119,598100.00%70,031,518Mar 31, 2024
REDMILE GROUP, LLC2.44%2.28%1,879,617449,83431.46%62,102,546Mar 31, 2024
ARK INVESTMENT MANAGEMENT LLC10.61%1.87%8,182,174-1,211,715-12.90%270,339,043,000Mar 31, 2024
CASDIN CAPITAL, LLC0.87%1.66%675,000147,00027.84%22,302,000Mar 31, 2024
YIHENG CAPITAL MANAGEMENT, L.P.1.10%1.55%845,500--27,935,320Mar 31, 2024
NIKKO ASSET MANAGEMENT AMERICAS, INC.3.06%0.77%2,361,8173,7260.16%77,892,725Mar 31, 2024
FARALLON CAPITAL MANAGEMENT LLC5.85%0.67%4,511,753406,0009.89%149,068,319Mar 31, 2024
BELLEVUE GROUP AG1.55%0.60%1,193,121498,30071.72%39,420,718Mar 31, 2024
CORMORANT ASSET MANAGEMENT, LP0.39%0.43%300,000300,000100.00%9,912,000Mar 31, 2024
ALPHABET INC.0.42%0.42%321,604--10,625,796Mar 31, 2024
SCIENTECH RESEARCH LLC0.03%0.34%19,40710,875127.46%641,207Mar 31, 2024
TEMASEK HOLDINGS (PRIVATE) LTD2.35%0.33%1,812,972-1,263,145-41.06%59,900,595Mar 31, 2024
GREEN ALPHA ADVISORS, LLC0.02%0.33%13,636-273-1.96%450,533Mar 31, 2024
BRANDYWINE MANAGERS, LLC0.01%0.26%8,067--266,534Mar 31, 2024
PDT PARTNERS, LLC0.07%0.17%55,64955,649100.00%1,838,643Mar 31, 2024
VESTMARK ADVISORY SOLUTIONS, INC.0.15%0.16%114,78616,57116.87%3,792,529Mar 31, 2024
CLARIUS GROUP, LLC0.08%0.14%60,615--2,002,720Mar 31, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.0.02%0.13%15,49615,496100.00%511,988Mar 31, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP0.19%0.12%147,51036,08032.38%4,873,730Mar 31, 2024

The largest Beam Therapeutics shareholder by % of total assets is MWG MANAGEMENT LTD.. The company owns 2.35M shares of Beam Therapeutics (BEAM), representing 57.42% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
DARWIN GLOBAL MANAGEMENT, LTD.2.75%9.32%2,119,5982,119,598100.00%70,031,518Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/1.62%0.01%1,246,1891,207,6993137.70%41,175,000Mar 31, 2024
BELLEVUE GROUP AG1.55%0.60%1,193,121498,30071.72%39,420,718Mar 31, 2024
REDMILE GROUP, LLC2.44%2.28%1,879,617449,83431.46%62,102,546Mar 31, 2024
VANGUARD GROUP INC9.82%0.01%7,578,768413,8925.78%250,402,494Mar 31, 2024
FARALLON CAPITAL MANAGEMENT LLC5.85%0.67%4,511,753406,0009.89%149,068,319Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.47%0.03%358,798358,798100.00%11,854,686Mar 31, 2024
CORMORANT ASSET MANAGEMENT, LP0.39%0.43%300,000300,000100.00%9,912,000Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.28%0.00%213,500213,500100.00%7,054,040Mar 31, 2024
TD ASSET MANAGEMENT INC0.21%0.01%162,692162,692100.00%5,375,344Mar 31, 2024
TWO SIGMA ADVISERS, LP0.19%0.01%148,200148,200100.00%4,896,528Mar 31, 2024
CASDIN CAPITAL, LLC0.87%1.66%675,000147,00027.84%22,302,000Mar 31, 2024
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC0.19%0.11%144,554144,554100.00%4,776,064Mar 31, 2024
BANK OF AMERICA CORP /DE/0.42%0.00%321,052126,72465.21%10,607,557,000Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.13%0.00%102,700102,700100.00%3,393,208Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.13%0.01%98,05598,055100.00%3,239,737Mar 31, 2024
WALLEYE CAPITAL LLC0.13%0.01%97,73797,737100.00%3,229,230Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.11%0.00%81,62981,629100.00%2,697,022Mar 31, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC0.31%0.03%236,38778,13949.38%7,810,226Mar 31, 2024
DIMENSIONAL FUND ADVISORS LP0.83%0.01%641,86175,00313.23%21,207,088Mar 31, 2024

As of Mar 31 2024, Beam Therapeutics's largest institutional buyer is DARWIN GLOBAL MANAGEMENT, LTD.. The company purchased 2.12M stocks of BEAM, valued at $70.03M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FMR LLC6.34%0.01%4,894,453-1,285,869-20.81%161,712,727Mar 31, 2024
TEMASEK HOLDINGS (PRIVATE) LTD2.35%0.33%1,812,972-1,263,145-41.06%59,900,595Mar 31, 2024
ARK INVESTMENT MANAGEMENT LLC10.61%1.87%8,182,174-1,211,715-12.90%270,339,043,000Mar 31, 2024
STATE STREET CORP4.84%0.01%3,731,192-885,166-19.17%123,278,584Mar 31, 2024
TANG CAPITAL MANAGEMENT LLC----350,000-100.00%-Mar 31, 2024
EVENTIDE ASSET MANAGEMENT, LLC----261,360-100.00%-Mar 31, 2024
CANDRIAM S.C.A.----212,665-100.00%-Mar 31, 2024
JANE STREET GROUP, LLC0.22%0.00%171,817-176,231-50.63%5,676,834Mar 31, 2024
BARCLAYS PLC0.11%0.00%86,676-161,708-65.10%2,864,000Mar 31, 2024
BANK OF NEW YORK MELLON CORP0.38%0.00%289,888-148,517-33.88%9,577,876Mar 31, 2024
RAFFERTY ASSET MANAGEMENT, LLC0.32%0.03%244,354-95,363-28.07%8,073,456Mar 31, 2024
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC----68,050-100.00%-Mar 31, 2024
MORGAN STANLEY5.34%0.01%4,123,575-60,767-1.45%136,242,931Mar 31, 2024
JPMORGAN CHASE & CO0.60%0.00%465,486-57,947-11.07%15,379,658Mar 31, 2024
PICTET ASSET MANAGEMENT HOLDING SA0.39%0.01%302,020-50,789-14.40%9,978,741Mar 31, 2024
AMERIPRISE FINANCIAL INC0.30%0.00%228,905-37,090-13.94%7,563,013Mar 31, 2024
HARBOR CAPITAL ADVISORS, INC.----34,918-100.00%-Mar 31, 2024
WALLEYE CAPITAL LLC0.00%0.00%3,200-34,100-91.42%105,728Mar 31, 2024
WALLEYE CAPITAL LLC0.00%0.00%1,800-28,600-94.08%59,472Mar 31, 2024
WALLEYE TRADING LLC----27,400-100.00%-Mar 31, 2024

As of Mar 31 2024, Beam Therapeutics's biggest institutional seller is FMR LLC. The company sold -1.29M shares of BEAM, valued at $161.71M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
DARWIN GLOBAL MANAGEMENT, LTD.2.75%9.32%2,119,5982,119,598100.00%70,031,518Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.47%0.03%358,798358,798100.00%11,854,686Mar 31, 2024
CORMORANT ASSET MANAGEMENT, LP0.39%0.43%300,000300,000100.00%9,912,000Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.28%0.00%213,500213,500100.00%7,054,040Mar 31, 2024
TD ASSET MANAGEMENT INC0.21%0.01%162,692162,692100.00%5,375,344Mar 31, 2024
TWO SIGMA ADVISERS, LP0.19%0.01%148,200148,200100.00%4,896,528Mar 31, 2024
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC0.19%0.11%144,554144,554100.00%4,776,064Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.13%0.00%102,700102,700100.00%3,393,208Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.13%0.01%98,05598,055100.00%3,239,737Mar 31, 2024
WALLEYE CAPITAL LLC0.13%0.01%97,73797,737100.00%3,229,230Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.11%0.00%81,62981,629100.00%2,697,022Mar 31, 2024
PDT PARTNERS, LLC0.07%0.17%55,64955,649100.00%1,838,643Mar 31, 2024
POINT72 HONG KONG LTD0.06%0.08%48,32548,325100.00%1,596,658Mar 31, 2024
TUDOR INVESTMENT CORP ET AL0.06%0.01%47,84547,845100.00%1,580,799Mar 31, 2024
BARCLAYS PLC0.06%0.00%47,00047,000100.00%1,553,000Mar 31, 2024
CAPTION MANAGEMENT, LLC0.05%0.02%35,00035,000100.00%1,156,400Mar 31, 2024
TWINBEECH CAPITAL LP0.04%0.02%34,64134,641100.00%1,144,539Mar 31, 2024
BAMCO INC /NY/0.04%0.00%30,00030,000100.00%991,200Mar 31, 2024
LMR PARTNERS LLP0.03%0.01%20,40020,400100.00%674,016Mar 31, 2024
0.02%0.02%18,62218,622100.00%615,271Mar 31, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.0.02%0.13%15,49615,496100.00%511,988Mar 31, 2024
PEARL RIVER CAPITAL, LLC0.02%0.08%15,42915,429100.00%509,774Mar 31, 2024
GOTHAM ASSET MANAGEMENT, LLC0.02%0.01%14,93214,932100.00%493,353Mar 31, 2024
CAPITAL FUND MANAGEMENT S.A.0.02%0.00%14,70014,700100.00%485,688Mar 31, 2024
CREATIVE PLANNING0.02%0.00%12,06112,061100.00%398,495Mar 31, 2024
COMMONWEALTH EQUITY SERVICES, LLC0.02%0.00%11,86411,864100.00%392,000Mar 31, 2024
NEW YORK LIFE INVESTMENT MANAGEMENT LLC0.01%0.00%10,73410,734100.00%354,651Mar 31, 2024
PEAK6 INVESTMENTS LLC0.01%0.00%10,70010,700100.00%353,528Mar 31, 2024
FISHMAN JAY A LTD/MI0.01%0.04%10,00010,000100.00%330,400Mar 31, 2024
BAYESIAN CAPITAL MANAGEMENT, LP0.01%0.03%8,8038,803100.00%290,851Mar 31, 2024
AQUATIC CAPITAL MANAGEMENT LLC0.01%0.01%7,9007,900100.00%261,016Mar 31, 2024
VERITION FUND MANAGEMENT LLC0.01%0.00%7,8947,894100.00%260,818Mar 31, 2024
STIFEL FINANCIAL CORP0.01%0.00%7,6267,626100.00%251,966Mar 31, 2024
STEEL PEAK WEALTH MANAGEMENT LLC0.01%0.01%7,5057,505100.00%247,966Mar 31, 2024
DLK INVESTMENT MANAGEMENT, LLC0.01%0.10%7,2257,225100.00%238,714Mar 31, 2024
THRIVE WEALTH MANAGEMENT, LLC0.01%0.05%6,9256,925100.00%228,802Mar 31, 2024
AQR CAPITAL MANAGEMENT LLC0.01%0.00%6,5246,524100.00%215,553Mar 31, 2024
MCGUIRE INVESTMENT GROUP, LLC0.01%0.03%6,2506,250100.00%206,500Mar 31, 2024
REYNDERS MCVEIGH CAPITAL MANAGEMENT, LLC0.01%0.01%6,0556,055100.00%201,000Mar 31, 2024
QUEST PARTNERS LLC0.01%0.03%4,9534,953100.00%163,647Mar 31, 2024
QUANTBOT TECHNOLOGIES LP0.00%0.01%2,8002,800100.00%92,512Mar 31, 2024
STRS OHIO0.00%0.00%1,5001,500100.00%49,000Mar 31, 2024
SANDY SPRING BANK0.00%0.00%1,2001,200100.00%39,648,000Mar 31, 2024
PACER ADVISORS, INC.0.00%0.00%1,1341,134100.00%37,467Mar 31, 2024
QUARRY LP0.00%0.01%800800100.00%26,432Mar 31, 2024
RIVERVIEW TRUST CO0.00%0.02%796796100.00%26,300Mar 31, 2024
TRUST CO OF VERMONT0.00%0.00%200200100.00%6,608Mar 31, 2024
RFP FINANCIAL GROUP LLC0.00%0.00%170170100.00%5,617Mar 31, 2024
CIBC PRIVATE WEALTH GROUP, LLC0.00%-150150100.00%4,899,000Mar 31, 2024
RALEIGH CAPITAL MANAGEMENT INC.0.00%0.00%100100100.00%3,304,000Mar 31, 2024
MACROVIEW INVESTMENT MANAGEMENT LLC0.00%0.00%8080100.00%2,644Mar 31, 2024
PISCATAQUA SAVINGS BANK0.00%0.00%5050100.00%1,652,000Mar 31, 2024
-0.00%1818100.00%595Mar 31, 2024
SMARTLEAF ASSET MANAGEMENT LLC-0.00%1515100.00%441,000Mar 31, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC--1414100.00%462Mar 31, 2024

Beam Therapeutics's largest new institutional shareholder by number of shares is DARWIN GLOBAL MANAGEMENT, LTD., purchased 2.12M shares, valued at $70.03M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
TANG CAPITAL MANAGEMENT LLC----350,000-100.00%-Mar 31, 2024
EVENTIDE ASSET MANAGEMENT, LLC----261,360-100.00%-Mar 31, 2024
CANDRIAM S.C.A.----212,665-100.00%-Mar 31, 2024
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC----68,050-100.00%-Mar 31, 2024
HARBOR CAPITAL ADVISORS, INC.----34,918-100.00%-Mar 31, 2024
WALLEYE TRADING LLC----27,400-100.00%-Mar 31, 2024
CAXTON ASSOCIATES LP----18,703-100.00%-Mar 31, 2024
CORTON CAPITAL INC.----11,903-100.00%-Mar 31, 2024
CIBC WORLD MARKET INC.----10,181-100.00%-Mar 31, 2024
TORNO CAPITAL, LLC----10,000-100.00%-Mar 31, 2024
CAPITAL IMPACT ADVISORS, LLC----8,229-100.00%-Mar 31, 2024
PARALLAX VOLATILITY ADVISERS, L.P.----7,400-100.00%-Mar 31, 2024
VIRTUS INVESTMENT ADVISERS, INC.----3,049-100.00%-Mar 31, 2024
ADVISORY SERVICES NETWORK, LLC----476-100.00%-Mar 31, 2024
VIRTUS FUND ADVISERS, LLC----467-100.00%-Mar 31, 2024
NEWBRIDGE FINANCIAL SERVICES GROUP, INC.----250-100.00%-Mar 31, 2024
ITAU UNIBANCO HOLDING S.A.----236-100.00%-Mar 31, 2024
GLASSMAN WEALTH SERVICES----120-100.00%-Mar 31, 2024
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO----50-100.00%-Mar 31, 2024
CUTLER GROUP LLC / CA----50-100.00%-Mar 31, 2024
CREWE ADVISORS LLC----6-100.00%-Mar 31, 2024

Beam Therapeutics's largest sold out institutional shareholder by shares sold is TANG CAPITAL MANAGEMENT LLC, sold -0.35M shares, valued at -, as of undefined.

Beam Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Ark ETF Trust1.02%8,205,123-364,328-4.25%Jan 31, 2024
Manager Directed Portfolios0.70%114,002--Jan 31, 2024
Kelly Strategic ETF Trust0.45%12,306--Feb 29, 2024
Ark Venture Fund0.19%17,9515,44743.56%Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS0.10%51,311--Dec 31, 2023
Nuveen NASDAQ 100 Dynamic Overwrite Fund0.08%10,281--Dec 31, 2023
FIDELITY MT VERNON STREET TRUST0.04%1,272,351-53,984-4.07%Feb 29, 2024
Federated Hermes MDT Series0.04%94,845--Jan 31, 2024
RENAISSANCE CAPITAL GREENWICH FUNDS0.04%23,223--Dec 31, 2023
FIDELITY ADVISOR SERIES VII0.03%280,000--Jan 31, 2024
Humankind Benefit Corp0.03%718-115-13.81%Dec 31, 2023
VICTORY VARIABLE INSURANCE FUNDS0.03%15,710--Dec 31, 2023
EntrepreneurShares Series Trust0.03%8,229-4,371-34.69%Dec 31, 2023
ALGER FUNDS0.03%29,561--Jan 31, 2024
Advantage Advisers Xanthus Fund, L.L.C.0.03%88,706--Mar 31, 2024
Voya VARIABLE PRODUCTS TRUST0.03%8,809--Dec 31, 2023
TEKLA LIFE SCIENCES INVESTORS0.03%15,817--Dec 31, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.03%11,0446886.64%Dec 31, 2023
AMG FUNDS III0.02%3,820--Feb 29, 2024
PRUDENTIAL JENNISON BLEND FUND, INC.0.02%13,483--Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND IV0.02%56,000--Dec 31, 2023
Listed Funds Trust0.02%9,597--Feb 29, 2024
QUANTITATIVE MASTER SERIES LLC0.02%127,2438,9667.58%Dec 31, 2023
Voya EQUITY TRUST0.02%27,819--Feb 29, 2024
FIDELITY SELECT PORTFOLIOS0.02%1,158,150--Feb 29, 2024
BlackRock Advantage SMID Cap Fund, Inc.0.02%3,131--Dec 29, 2023
T. Rowe Price New Horizons Fund, Inc.0.02%236,893--Dec 31, 2023
VANGUARD INDEX FUNDS0.02%7,351,8641,371,57322.93%Dec 31, 2023
ACAP Strategic Fund0.02%213,102--Dec 31, 2023
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)0.01%91,200--Dec 31, 2023
FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND0.01%53,200--Jan 31, 2024
BlackRock Health Sciences Trust II0.01%35,888--Dec 31, 2023
FIDELITY COMMONWEALTH TRUST0.01%32,7175271.64%Feb 29, 2024
Jacob Funds Inc.0.01%2,188-2,527-53.59%Feb 29, 2024
FIDELITY CAPITAL TRUST0.01%82,900--Jan 31, 2024
TIAA SEPARATE ACCOUNT VA 10.01%1,758--Dec 31, 2023
Harbor ETF Trust0.01%35,3354,25513.69%Jan 31, 2024
DEUTSCHE DWS SECURITIES TRUST0.01%3,600--Feb 29, 2024
SMALLCAP WORLD FUND INC0.01%442,725--Dec 31, 2023
RYDEX SERIES FUNDS0.01%25,183-5,594-18.18%Dec 31, 2023
LORD ABBETT SECURITIES TRUST0.01%26,003--Jan 31, 2024
Nushares ETF Trust0.01%38,992--Jan 31, 2024
Fidelity Central Investment Portfolios LLC0.01%100,000--Feb 29, 2024
ProFunds0.00%37,17617,52589.18%Jan 31, 2024
FORUM FUNDS II0.00%3,320--Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND0.00%63,170-5,292-7.73%Dec 31, 2023
AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC.0.00%8,000--Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%691,84349,6757.74%Feb 29, 2024
DRIEHAUS MUTUAL FUNDS0.00%26,576--Dec 29, 2023
Calvert Variable Products, Inc.0.00%7,50371310.50%Dec 31, 2023
VANGUARD EXPLORER FUND0.00%37,652--Jan 31, 2024
PROFESSIONALLY MANAGED PORTFOLIOS0.00%15,356--Feb 29, 2024
NEUBERGER BERMAN EQUITY FUNDS0.00%26,412--Feb 29, 2024
IndexIQ ETF Trust0.00%5,289--Jan 31, 2024
RYDEX VARIABLE TRUST0.00%2,712-665-19.69%Dec 31, 2023
FIRST TRUST EXCHANGE-TRADED FUND0.00%23,830--Dec 31, 2023
John Hancock Exchange-Traded Fund Trust0.00%13,683--Jan 31, 2024
Direxion Shares ETF Trust0.00%326,17159,07322.12%Jan 31, 2024
SCHWAB STRATEGIC TRUST0.00%370,38027,1037.90%Feb 29, 2024
ETFis Series Trust I0.00%2,7552,755-Jan 31, 2024
Mutual of America Variable Insurance Portfolios, Inc.0.00%1,292--Sep 30, 2023
Destra Investment Trust0.00%2,714--Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%47,486--Dec 31, 2023
BNY Mellon Strategic Funds, Inc.0.00%3,435--Mar 31, 2024
BARON SELECT FUNDS0.00%15,717--Dec 31, 2023
MUTUAL OF AMERICA INVESTMENT CORP0.00%51,770--Dec 31, 2023
BLACKROCK LARGE CAP SERIES FUNDS, INC.0.00%47,552--Feb 29, 2024
HUSSMAN INVESTMENT TRUST0.00%3,600--Dec 31, 2023
VANGUARD WORLD FUND0.00%245,11111,6194.98%Feb 29, 2024
OLD WESTBURY FUNDS INC0.00%129,469-82,598-38.95%Jan 31, 2024
Fidelity Commonwealth Trust II0.00%6,310--Aug 31, 2023
MORGAN STANLEY INSTITUTIONAL FUND INC0.00%47,860-1,257-2.56%Dec 31, 2023
Voya VARIABLE PORTFOLIOS INC0.00%28,5729413.41%Dec 31, 2023
AMERICAN PENSION INVESTORS TRUST0.00%5,005--Jan 31, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%2,959--Dec 31, 2023
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%3,442-186-5.13%Dec 31, 2023
T. Rowe Price Index Trust, Inc.0.00%13,025--Feb 29, 2024
FIDELITY COVINGTON TRUST0.00%10,183--Feb 29, 2024
DEUTSCHE DWS VARIABLE SERIES II0.00%1,593--Dec 31, 2023
Principal Exchange-Traded Funds0.00%8,533-702-7.60%Mar 31, 2024
OHIO NATIONAL FUND INC0.00%13,653--Dec 31, 2023
Dimensional ETF Trust0.00%288,03279,28337.98%Jan 31, 2024
AMERICAN CENTURY ETF TRUST0.00%71,69030,33273.34%Feb 29, 2024
SunAmerica Specialty Series0.00%291--Apr 30, 2021
VARIABLE INSURANCE PRODUCTS FUND II0.00%7,021-1,502-17.62%Dec 31, 2023
JPMORGAN INSURANCE TRUST0.00%6,156-244-3.81%Mar 31, 2023
FIDELITY ADVISOR SERIES I0.00%83,761-105-0.13%Feb 29, 2024
TIAA-CREF LIFE FUNDS0.00%1,068--Dec 31, 2023
Meeder Funds0.00%1,858--Mar 31, 2024
Spinnaker ETF Series0.00%245--Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND III0.00%2,900--Dec 31, 2023
BlackRock ETF Trust0.00%268181208.05%Jan 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%26,2002,70011.49%Dec 31, 2023
RUSSELL INVESTMENT CO0.00%86,094-5,734-6.24%Jan 31, 2024
BNY MELLON FUNDS TRUST0.00%16,45516,455-Feb 29, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%16,791180.11%Jan 31, 2024
EQ ADVISORS TRUST0.00%218,6914,0381.88%Dec 31, 2023
HC CAPITAL TRUST0.00%5,353--Dec 31, 2023
VANGUARD SCOTTSDALE FUNDS0.00%332,14950,59817.97%Feb 29, 2024
MASTER INVESTMENT PORTFOLIO0.00%13,3164,08744.28%Dec 31, 2023

Beam Therapeutics's largest mutual fund holder by % of total assets is "Ark ETF Trust", owning 8.21M shares, compromising 1.02% of its total assets.

Beam Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 24154-18.95%
31 Dec, 23190-2.56%
30 Sep, 23195-
30 Jun, 23195-6.70%
31 Mar, 23209-4.13%
31 Dec, 22218-2.68%
30 Sep, 2222413.71%
30 Jun, 22197-17.23%
31 Mar, 222382.15%
31 Dec, 212330.87%
30 Sep, 21231-3.75%
30 Jun, 212409.09%
31 Mar, 2122037.50%
31 Dec, 2016090.48%
30 Sep, 208418.31%
30 Jun, 207118.33%
31 Mar, 2060-

As of 31 Mar 24, 154 institutions are holding Beam Therapeutics's shares, representing a decrease of -18.95% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2444,098,162-35.76%
31 Dec, 2368,645,7612.57%
30 Sep, 2366,926,4744.85%
30 Jun, 2363,832,7086.81%
31 Mar, 2359,761,0327.01%
31 Dec, 2255,846,4102.56%
30 Sep, 2254,452,416-0.44%
30 Jun, 2254,690,44311.32%
31 Mar, 2249,128,5408.12%
31 Dec, 2145,437,2000.77%
30 Sep, 2145,090,144-0.80%
30 Jun, 2145,452,3506.42%
31 Mar, 2142,709,53515.94%
31 Dec, 2036,837,15624.77%
30 Sep, 2029,524,6236.56%
30 Jun, 2027,707,8883.05%
31 Mar, 2026,888,544-

Beam Therapeutics (BEAM) has 44.10M shares outstanding as of 31 Mar 24, down -35.76% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2457.16%0.76%
31 Dec, 2386.87%1.13%
30 Sep, 2387.67%1.12%
30 Jun, 2388.32%1.29%
31 Mar, 2382.69%1.30%
31 Dec, 2279.76%1.33%
30 Sep, 2277.41%1.28%
30 Jun, 2277.90%1.52%
31 Mar, 2271.51%1.60%
31 Dec, 2166.83%1.45%
30 Sep, 2167.93%1.27%
30 Jun, 2173.06%1.45%
31 Mar, 2170.93%1.90%
31 Dec, 2061.18%1.76%
30 Sep, 2058.95%1.88%
30 Jun, 2056.05%0.73%
31 Mar, 2087.51%-

As of 31 Mar 24, Beam Therapeutics is held by 57.16% institutional shareholders, representing a 0.76% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 2489-12.75%
31 Dec, 23102-8.93%
30 Sep, 2311214.29%
30 Jun, 2398-5.77%
31 Mar, 23104-9.57%
31 Dec, 22115-1.71%
30 Sep, 22117-0.85%
30 Jun, 22118-15.71%
31 Mar, 2214018.64%
31 Dec, 21118-11.28%
30 Sep, 21133-6.34%
30 Jun, 211427.58%
31 Mar, 211329.09%
31 Dec, 20121116.07%
30 Sep, 205627.27%
30 Jun, 2044-26.67%
31 Mar, 2060-

89 institutional shareholders have increased their position in BEAM stock as of 31 Mar 24 compared to 102 in the previous quarter (a -12.75% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 2431-41.51%
31 Dec, 235329.27%
30 Sep, 2341-2.38%
30 Jun, 2342-26.32%
31 Mar, 2357-
31 Dec, 2257-10.94%
30 Sep, 226468.42%
30 Jun, 2238-13.64%
31 Mar, 2244-34.33%
31 Dec, 216752.27%
30 Sep, 2144-6.38%
30 Jun, 214714.63%
31 Mar, 2141355.56%
31 Dec, 209-10.00%
30 Sep, 2010-
30 Jun, 2010-
31 Mar, 20--

31 institutional shareholders have reduced their position in BEAM stock as of 31 Mar 24 compared to 53 in the previous quarter (a -41.51% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 24154-18.95%44,098,162-35.76%57.16%0.76%89-12.75%31-41.51%
31 Dec, 23190-2.56%68,645,7612.57%86.87%1.13%102-8.93%5329.27%
30 Sep, 23195-66,926,4744.85%87.67%1.12%11214.29%41-2.38%
30 Jun, 23195-6.70%63,832,7086.81%88.32%1.29%98-5.77%42-26.32%
31 Mar, 23209-4.13%59,761,0327.01%82.69%1.30%104-9.57%57-
31 Dec, 22218-2.68%55,846,4102.56%79.76%1.33%115-1.71%57-10.94%
30 Sep, 2222413.71%54,452,416-0.44%77.41%1.28%117-0.85%6468.42%
30 Jun, 22197-17.23%54,690,44311.32%77.90%1.52%118-15.71%38-13.64%
31 Mar, 222382.15%49,128,5408.12%71.51%1.60%14018.64%44-34.33%
31 Dec, 212330.87%45,437,2000.77%66.83%1.45%118-11.28%6752.27%
30 Sep, 21231-3.75%45,090,144-0.80%67.93%1.27%133-6.34%44-6.38%
30 Jun, 212409.09%45,452,3506.42%73.06%1.45%1427.58%4714.63%
31 Mar, 2122037.50%42,709,53515.94%70.93%1.90%1329.09%41355.56%
31 Dec, 2016090.48%36,837,15624.77%61.18%1.76%121116.07%9-10.00%
30 Sep, 208418.31%29,524,6236.56%58.95%1.88%5627.27%10-
30 Jun, 207118.33%27,707,8883.05%56.05%0.73%44-26.67%10-
31 Mar, 2060-26,888,544-87.51%-60---

Beam Therapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 03, 2024Simon Amyofficer Chief Medical OfficerS-SaleSell7,157$32.13$229.95K86,590
Apr 03, 2024Simon Amyofficer Chief Medical OfficerS-SaleSell16,530$30.54$504.85K70,060
Apr 03, 2024Bellon Christineofficer Chief Legal OfficerS-SaleSell3,401$32.12$109.24K104,594
Apr 03, 2024Burrell Terry-Annofficer Chief Financial OfficerS-SaleSell5,446$32.12$174.93K70,137
Apr 03, 2024Evans John M.director, officer CEOS-SaleSell18,102$32.13$581.62K1,058,343
Apr 03, 2024Ciaramella Giuseppeofficer PresidentS-SaleSell4,534$32.12$145.63K169,616
Apr 01, 2024Evans John M.director, officer CEOS-SaleSell60,000$33.86$2.03M998,262
Feb 15, 2024FMR LLCother See Remark 1S-SaleSell410$30.28$12.41K2,773,068
Feb 15, 2024FMR LLCother See Remark 1S-SaleSell1,155$30.93$35.72K2,771,913

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 03, 2024Simon Amyofficer Chief Medical OfficerS-SaleSell7,157$32.13$229.95K86,590
Apr 03, 2024Simon Amyofficer Chief Medical OfficerS-SaleSell16,530$30.54$504.85K70,060
Apr 03, 2024Bellon Christineofficer Chief Legal OfficerS-SaleSell3,401$32.12$109.24K104,594
Apr 03, 2024Burrell Terry-Annofficer Chief Financial OfficerS-SaleSell5,446$32.12$174.93K70,137
Apr 03, 2024Evans John M.director, officer CEOS-SaleSell18,102$32.13$581.62K1,058,343
Apr 03, 2024Ciaramella Giuseppeofficer PresidentS-SaleSell4,534$32.12$145.63K169,616
Apr 01, 2024Evans John M.director, officer CEOS-SaleSell60,000$33.86$2.03M998,262
Feb 15, 2024FMR LLCother See Remark 1S-SaleSell410$30.28$12.41K2,773,068
Feb 15, 2024FMR LLCother See Remark 1S-SaleSell1,155$30.93$35.72K2,771,913

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 29, 2024Burrell Terry-Annofficer Chief Financial OfficerA-AwardBuy12,500--82,637
Apr 29, 2024Burrell Terry-Annofficer Chief Financial OfficerA-AwardBuy25,000$30.87$771.75K25,000
Apr 03, 2024Simon Amyofficer Chief Medical OfficerS-SaleSell7,157$32.13$229.95K86,590
Apr 03, 2024Simon Amyofficer Chief Medical OfficerS-SaleSell16,530$30.54$504.85K70,060
Apr 03, 2024Bellon Christineofficer Chief Legal OfficerS-SaleSell3,401$32.12$109.24K104,594
Apr 03, 2024Burrell Terry-Annofficer Chief Financial OfficerS-SaleSell5,446$32.12$174.93K70,137
Apr 03, 2024Evans John M.director, officer CEOS-SaleSell18,102$32.13$581.62K1,058,343
Apr 03, 2024Evans John M.director, officer CEOA-AwardBuy99,336$0.67$66.56K99,336
Apr 03, 2024Evans John M.director, officer CEOA-AwardBuy53,965$4.22$227.73K53,965
Apr 03, 2024Ciaramella Giuseppeofficer PresidentS-SaleSell4,534$32.12$145.63K169,616
Apr 03, 2024Ciaramella Giuseppeofficer PresidentA-AwardBuy27,318$0.67$18.30K27,318
Apr 03, 2024Ciaramella Giuseppeofficer PresidentA-AwardBuy12,979$4.22$54.77K12,979
Apr 02, 2024Burrell Terry-Annofficer Chief Financial OfficerA-AwardBuy27,500--75,583
Apr 02, 2024Simon Amyofficer Chief Medical OfficerA-AwardBuy27,500--93,747
Apr 02, 2024Ciaramella Giuseppeofficer PresidentA-AwardBuy35,000--174,150
Apr 02, 2024Bellon Christineofficer Chief Legal OfficerA-AwardBuy27,500--107,995
Apr 01, 2024Evans John M.director, officer CEOA-AwardBuy77,500--1,076,445
Apr 01, 2024Evans John M.director, officer CEOS-SaleSell60,000$33.86$2.03M998,262
Feb 15, 2024FMR LLCother See Remark 1S-SaleSell410$30.28$12.41K2,773,068
Feb 15, 2024FMR LLCother See Remark 1S-SaleSell1,155$30.93$35.72K2,771,913

The last insider sell of Beam Therapeutics's stock was made by Simon Amy on Apr 03 2024, selling 7,157 shares at $32.13 per share (valued at $229.95K).

Beam Therapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20331--
Q2 202466100.00%
Q1 2024107142.86%
Q4 20234850.00%
Q3 20233650.00%
Q2 202351145.45%
Q1 2023212972.41%
Q4 202231520.00%
Q3 2022168200.00%
Q2 20224944.44%
Q1 202271643.75%
Q4 202162030.00%
Q3 2021194740.43%
Q2 2021314864.58%
Q1 2021252792.59%
Q4 20202219.52%
Q3 202032150.00%
Q2 202011100.00%
Q1 2020192965.52%
Q1 2014-2-

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Beam Therapeutics's insiders, as of Q2 2033.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2033---
Q2 2024-6-
Q1 2024-7-
Q4 2023-4-
Q3 2023-3-
Q2 2023-11-
Q1 2023-7-
Q4 2022-11-
Q3 2022-4-
Q2 2022-5-
Q1 2022-15-
Q4 2021-14-
Q3 2021-31-
Q2 2021-27-
Q1 2021-7-
Q4 2020-19-
Q3 2020---
Q2 2020---
Q1 2020---
Q1 2014-2-

As of Q2 2033, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Beam Therapeutics's stocks.

Beam Therapeutics Peer Ownership


TickerCompany
VERVVerve Therapeutics, Inc.
FATEFate Therapeutics, Inc.
DNAGinkgo Bioworks Holdings, Inc.
PRMEPrime Medicine, Inc.
CRSPCRISPR Therapeutics AG
NTLAIntellia Therapeutics, Inc.
VRTXVertex Pharmaceuticals Incorporated
CRBUCaribou Biosciences, Inc.
EDITEditas Medicine, Inc.
SANASana Biotechnology, Inc.

BEAM Ownership FAQ


Beam Therapeutics is owned by institutional shareholders (57.16%), insiders (1.52%), and public (41.32%). The largest institutional shareholder of Beam Therapeutics is ARK INVESTMENT MANAGEMENT LLC (10.61% of total shares) and the top mutual fund owner is Ark ETF Trust (1.02% of total shares).

Beam Therapeutics's major institutional shareholders are ARK INVESTMENT MANAGEMENT LLC, VANGUARD GROUP INC, BLACKROCK INC., FMR LLC, and FARALLON CAPITAL MANAGEMENT LLC. The top five shareholders own together 41.31% of the company's share outstanding.

As of Mar 2024, there are 154 institutional shareholders of Beam Therapeutics.

ARK INVESTMENT MANAGEMENT LLC owns 8.18M shares of Beam Therapeutics, representing 10.61% of the company's total shares outstanding, valued at $270.34B (as of Mar 2024).

As of Mar 2024, VANGUARD GROUP INC holds 7.58M shares of Beam Therapeutics (BEAM), compromising 9.82% of the company, valued at $250.4M.

BLACKROCK INC is the third largest holder of Beam Therapeutics. The company owns 6.71M of the company's shares outstanding (worth $221.55M).